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Background:  The purpose of this study was to examine the effect of atrial fibrillation (AF) on the immediate and long-term outcome of patients 
undergoing balloon mitral valvotomy (BMV).
Methods:  818 consecutive patients, who underwent elective Balloon Mitral Valvotomy in this Institute from 1997 to 2003, with either double 
lumen or triple lumen BMV catheters, were included in the study. Of them, 95 were in AF. The clinical, echocardiographic and hemodynamic data of 
these patients were compared with those of 723 patients in normal sinus rhythm (NSR). Immediate procedural results and long term events were 
compared between the two study groups.
Results: Patients with AF were older (29.4 ± 10.1 vs. 39.9 ± 9.9 years; p < 0.001) and presented more frequently with New York Heart Association 
(NYHA) class III-IV (32.9% vs. 53.7%; p = 0.001), echocardiographic score >8 (24.9% vs. 47.4%; p = 0.001) and with history of previous surgical 
commissurotomy (11.5% vs. 33.7%; p = 0.002). In patients with AF, BMV resulted in inferior immediate and long-term outcomes, as reflected in a 
lesser post-BMV mitral valve area (1.5 + 0.4 vs. 1.3 + 0.3 cm2; p = 0.04) and a lower event free survival (freedom of death, reintervention, mitral 
valve replacement surgery, stroke and death) at a mean follow-up time of 60 months (82.5% vs. 78.3%; p = 0.065). In the group of patients in AF, 
echocardiographic score >8 (p = 0.04) was identified as the sole independent predictor of combined events at follow-up.
Conclusions: Patients with AF have worse immediate and long-term outcomes after BMV. AF is a marker for clinical and morphologic features 
associated with inferior results after BMV.
